Previous slide
Next slide

Our Mission

It is the mission of the CSNK2B Foundation to bring awareness and education to CSNK2B Neurodevelopmental Syndrome and to enrich the lives of those affected by accelerating research, treatments and by chasing a cure for CSNK2B.

What is CSNK2B?

CSNK2B Neurodevelopmental Syndrome was first identified in 2017. It is a rare genetic disorder often characterized by early-onset seizures, global developmental delays and varying levels of intellectual disability (ID). 

What causes CSNK2B Neurodevelopmental Syndrome:

It is caused by a heterozygous mutation in the CSNK2B gene (115441) on chromosome 6p21

How many patients are diagnosed?

Around 75-100 patients have been diagnosed with CSNK2B Neurodevelopmental Syndrome. This number is expected to increase with the use of Exome Sequencing.

Are there treatment options for CSNK2b?

 

Currently there is no treatment or cure for CSNK2B

Resources

Articles related to CSNK2B

Scientific Reports

A short description of the service and how the visitor will benefit from it.

Resources for Parents

A short description of the service and how the visitor will benefit from it.

Report from HGVS

A short description of the service and how the visitor will benefit from it.

POBINDS Info

A short description of the service and how the visitor will benefit from it.

Currently there is no treatment or cure for CSNK2B

Around 75-100 patients have been diagnosed with CSNK2B Neurodevelopmental Syndrome. This number is expected to increase with the use of Exome Sequencing.

© 2022 All Rights Reserved.